Showing results (691-700 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|April 22, 2020
Comparative Study of Traditional Ablative CO2 Laser-Assisted Topical Antifungal with only Topical Antifungal for Treating Onychomycosis: A Multicenter StudyBhavana Rajbanshi, Liangliang Shen, Miao Jiang, et al.
Clinical Drug Investigation|April 29, 2020
Efficacy of Collagenase Clostridium histolyticum (Xiapex®) in Patients with the Acute Phase of Peyronie's DiseaseAndrea Cocci, Fabrizio Di Maida, Giorgio Ivan Russo, et al.
Clinical Drug Investigation|August 14, 2016
Pharmacodynamic Effects of Sulodexide on Profibrinolytic and Haemorrheological PatternsG L Messa, G La Placa, L Puccetti, et al.
Clinical Drug Investigation|August 14, 2016
L-Acetylcarnitine in the Treatment of Patients with Peripheral Neuropathies : A Short Term, Double-Blind Clinical Study of 426 PatientsD De Grandis, L Santoro, P Di Benedetto
Clinical Drug Investigation|August 14, 2016
Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled StudyG Nappi, G Bono, P Merlo, et al.
Clinical Drug Investigation|August 14, 2016
Flecainide-induced Increase in QRS Duration and Proarrhythmia during ExerciseP Bordier, S Garrigue, V Bernard, et al.
Clinical Drug Investigation|August 17, 2021
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Clinical Drug Investigation|August 9, 2021
Efficacy and Tolerability of Oral Compared with Sublingual Ketamine Lozenges as Rescue Analgesics in Adults for Acute Pain: The OSKet TrialChui C Chong, Stephan A Schug
Clinical Drug Investigation|August 24, 2021
Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study 'TOPICS Greece'Dardiotis Efthimios, Karachalios Georgios, Alexopoulou Antonia, et al.
Clinical Drug Investigation|August 1, 2021
Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous YearPier Paolo Mangia, Ottavio Gallo, Daniela Ritrovato, et al.
Pageof 234